To determine the functional importance of PP2A in regulating ERK activation of DP thymocytes in the context of thymic lymphoma, we used a selective PP2A inhibitor, LB‐100 that is suitable for in vivo via intraperitoneal injection in an ENU‐induced tumor model (Figure 7A). Here, PTPA is linked to thymus lymphoma.